JP Morgan Chase’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

JP Morgan Chase’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-106,300	Closed	-$2.28M	–	7426
2022 Q4	$2.28M	Buy	+106,300	New	+$2.27M	﹤0.01%	3466

JP Morgan Chase's ISEE Position: Q3 2023 in Review

JP Morgan Chase sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 403,077 shares — an estimated $15.9M sold.

JP Morgan Chase first reported a position in ISEE in Q4 2013 and held it in 37 quarters. The position peaked at $19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

JP Morgan Chase reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
JP Morgan Chase sold 403,077 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $15.9M.
JP Morgan Chase first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 37 quarters.
JP Morgan Chase's IVERIC bio, Inc. Common Stock position peaked at $19M in Q1 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.